These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Functional imaging for disorders of basal ganglia]. Otsuka M, Taniwaki T. Rinsho Shinkeigaku; 1999 Jan; 39(1):30-2. PubMed ID: 10377793 [Abstract] [Full Text] [Related]
3. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease. Thobois S, Guillouet S, Broussolle E. Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273 [Abstract] [Full Text] [Related]
4. [Positron emission tomography and basal ganglia functions]. Kato M. No To Shinkei; 1990 May; 42(5):450-60. PubMed ID: 2206633 [No Abstract] [Full Text] [Related]
5. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Booij J, Tissingh G, Winogrodzka A, van Royen EA. Eur J Nucl Med; 1999 Feb; 26(2):171-82. PubMed ID: 9933352 [Abstract] [Full Text] [Related]
6. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RS. Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742 [Abstract] [Full Text] [Related]
7. [Challenges in the differential diagnoses of parkinsonism]. Bech S, Haugbøl S, Winge K. Ugeskr Laeger; 2017 Aug 14; 179(33):. PubMed ID: 28869013 [Abstract] [Full Text] [Related]
8. Positron emission tomography in degenerative disorders of the dopaminergic system. Karbe H, Holthoff V, Huber M, Herholz K, Wienhard K, Wagner R, Heiss WD. J Neural Transm Park Dis Dement Sect; 1992 Aug 14; 4(2):121-30. PubMed ID: 1571076 [Abstract] [Full Text] [Related]
9. DAT imaging in drug-induced and psychogenic parkinsonism. Tolosa E, Coelho M, Gallardo M. Mov Disord; 2003 Oct 14; 18 Suppl 7():S28-33. PubMed ID: 14531043 [Abstract] [Full Text] [Related]
10. SPECT Molecular Imaging in Atypical Parkinsonism. Brumberg J, Isaias IU. Int Rev Neurobiol; 2018 Oct 14; 142():37-65. PubMed ID: 30409259 [Abstract] [Full Text] [Related]
12. Positron emission tomography and central neurotransmitter systems in movement disorders. Weeks RA, Brooks DJ. Fundam Clin Pharmacol; 1994 Oct 14; 8(6):503-17. PubMed ID: 7721227 [Abstract] [Full Text] [Related]
19. PET studies on the early and differential diagnosis of Parkinson's disease. Brooks DJ. Neurology; 1993 Dec 14; 43(12 Suppl 6):S6-16. PubMed ID: 8264913 [Abstract] [Full Text] [Related]
20. The role of positron emission tomography imaging in movement disorders. Bohnen NI, Frey KA. Neuroimaging Clin N Am; 2003 Nov 14; 13(4):791-803. PubMed ID: 15024962 [Abstract] [Full Text] [Related] Page: [Next] [New Search]